Trial NCT02893332

View at ClinicalTrials.gov 
Org. Study IDs: 2016 15-1

Last trial update was posted on 2021-02-03

MeSH Interventions

Erlotinib Hydrochloride Gefitinib

MeSH Conditions

Adenocarcinoma Adenocarcinoma of Lung

Other Conditions

Stage IV EGFR Mutated Non-Small Cell Lung Cancer

Stopping Reasons

After interim analysis, IRB recommend termination.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID